CompletedNot Applicable

Retrospective Comparative Outcomes of Gamma and InterTAN Nail for Unstable Intertrochanteric Hip Fractures

Spain686 participantsStarted 2025-12-13

Plain-language summary

Objective: compare outcomes of unstable intertrochanteric hip fractures treated with two commercially available implants. Design: retrospective observational cohort of 288 treated with a Gamma® nail and 398 with an InterTAN® nail. Patients were operated between 1997 and 2010. Primary outcomes: satisfactory reduction, optimal cephalic screw placement, and to evaluate the incidence of mechanical complications; secondary measures included the tip-apex distance (TAD), hematocrit (Hto) and hemoglobin (Hb) drop, transfusion requirement and volume, hospital length of stay and the time to first ambulation.

Who can participate

Age range65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Unstable trochanteric fractures confirmed radiographically according to OTA (Orthopedic Trauma Association), treated with Gamma or InterTAN nail, * available follow-up for ≥ 6 months Exclusion Criteria: * Pathological fractures * Polytrauma precluding standard treatment/follow-up * Missing key variables/outcomes

What they're measuring

Implant-related complications

Timeframe: 6 months

Trial details

NCT IDNCT07282236

SponsorFundación Universidad Católica de Valencia San Vicente Mártir

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2026-01-12

View on ClinicalTrials.gov More Unstable Throchanteric Hip Fractures trials